Ignite Creation Date:
2024-05-06 @ 1:39 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04084951
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2019-09-01
Brief Title:
Study of SQZ-PBMC-HPV in Patients With HPV16 Recurrent Locally Advanced or Metastatic Solid Tumors
Sponsor:
SQZ Biotechnologies
Organization:
SQZ Biotechnologies
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Solid Tumor |
Keywords:
| Name | View |
|---|---|
| antigen presenting cells | View |
| recurrent cancer | View |
| metastatic | View |
| locally advanced | View |
| cancer | View |
| cervical | View |
| head and neck | View |
| anal | View |
| penile | View |
| SQZ-PBMC-HPV | View |
| atezolizumab | View |
| HPV16 | View |
| APC | View |
| cell therapy | View |
| ipilimumab | View |
| nivolumab | View |
| checkpoint inhibitors | View |
| immunotherapy | View |
| solid tumor | View |
| HLA-A02 | View |
| therapeutic vaccine | View |
| advanced solid tumor | View |
| rectal | View |
| vulvar | View |
| vaginal | View |
| PBMC | View |
| human papillomavirus strain 16 | View |
| peripheral blood mononuclear cells | View |